In The News

Ropes & Gray Represents The Vistria Group and Excellere Partners in its Investment in SCA Pharmaceuticals

Practices: Private Equity, Tax, Executive Compensation & Employee Benefits, Finance, Securities & Futures Enforcement, Health Care, Life Sciences

Ropes & Gray represented The Vistria Group and Excellere Partners in its investment in SCA Pharmaceuticals. The terms of the transaction, which was announced on Jan. 21, were not disclosed. The press release is here. 

SCA Pharma is an FDA-registered outsourcing facility serving over 1,200 hospitals and health systems in the United States. The Vistria Group is a Chicago-based private investment firm focused on investing in middle market companies in the health care, education, and financial services sectors. Excellere Partners is a Denver-based private equity firm with $1.36 billion of committed capital across three funds which partner with entrepreneurs and management teams through recapitalizations and management buyouts. 

The Ropes & Gray team that represented The Vistria Group and Excellere Partners was led by private equity partners Neill Jakobe and Timothy Castelli (both of Chicago), and included  employment, executive compensation & benefits partner Jennifer Cormier (Boston), tax partner Aaron Harsh (Boston), finance partner Andrea Hwang (New York), litigation & enforcement partner Timothy Farrell (Chicago), real estate partner Alison Rundlett (Boston), health care partner Deborah Gersh (Chicago), life sciences regulatory & compliance partner Gregory Levine (Washington D.C.), and private equity associate Andrew Pomranke (Chicago).

Cookie Settings